JNJ vs MRK
By Alex · Tickerpine
Johnson & Johnson vs Merck & Company, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MRK |
|---|---|---|
| Price | $260.86 | $132.92 |
| Market cap | $628.65B | $327.94B |
| P/E ratio | 30.3 | 106.3 |
| ROE | 25.74% | 6.96% |
| Profit margin | 21.48% | 4.77% |
| Revenue growth | 6.60% | 5.10% |
| Dividend yield | 2.05% | 2.56% |
| Beta | 0.23 | 0.21 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MRK in plain English
- JNJ is the bigger company — about 1.9× the market cap of MRK.
- JNJ is cheaper on earnings (P/E 30.3 vs 106.3).
- JNJ earns a higher return on equity (26% vs 7%).
- JNJ is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.56% vs 2.05%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.